EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease

Elżbieta Lorenc-Koci iD, Tomasz Lenda iD, Jolanta Konieczny iD, Danuta Jantas iD, Helena Domin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26188833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Elżbieta Lorenc-Koci und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland. Hauptthemen laut MEDLINE: Dopamine, Calcium Channel Blockers, Substantia Nigra, Dopaminergic Neurons. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Statutory Fund of the Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selective proteasome inhibitors, used to model Parkinsonian-like pathology, are known to disrupt calcium homeostasis, but the role of calcium ions in dopaminergic neuron degeneration remains unclear. The present in vivo study examined the effects of a 7-day intraperitoneal administration of cinnarizine (10 or 30 mg/kg), a voltage-gated calcium channel blocker, in rats unilaterally injected into the substantia nigra compacta (SNc) with lactacystin (Lac; 1 µg/2 µL) or vehicle. Dopamine (DA) and its metabolites were quantified in striatal homogenates via high-performance liquid chromatography. The SN of rats treated with 10 mg/kg cinnarizine was used for Western blot analysis of tyrosine hydroxylase (TH), while tissue from animals receiving 30 mg/kg was processed for histological analysis of TH-immunoreactive (TH-ir) and cresyl violet (CV)-stained neurons. Significant reductions in striatal DA and its metabolites were observed one week after Lac injection, along with increased DA catabolism. Cinnarizine at both doses partially prevented DA loss and attenuated enhanced DA turnover. Moreover, 10 mg/kg cinnarizine partially preserved TH protein levels, while 30 mg/kg provided histological protection of TH-ir neurons in the SN. Cinnarizine was also tested in vitro in human SH-SY5Y neuroblastoma cells and primary mouse cortical neurons exposed to Lac or rotenone to further assess its neuroprotective potential. In SH-SY5Y cells, cinnarizine (1–10 µM) significantly increased cell viability and reduced lactate dehydrogenase release after toxin exposure. Cinnarizine failed to counteract lactacystin-induced toxicity in primary cortical neurons but markedly reduced rotenone-evoked cell death at similar concentrations. These findings indicate that cinnarizine exerts dose-dependent neuroprotective effects in vivo and selective protective actions in vitro, supporting the potential utility of voltage-gated calcium channel blockers in treating Parkinson’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DopamineCalcium Channel BlockersSubstantia NigraDopaminergic NeuronsCorpus StriatumCinnarizineParkinson DiseaseAnimalsRatsAcetylcysteineMaleDisease Models, AnimalHumansRats, Sprague-DawleyMiceTyrosine 3-Monooxygenase

Stichwörter der Autor:innen

cinnarizinedopamine metabolismlactacystin-induced model of Parkinson’s diseaseproteasome inhibitor lactacystinsubstantia nigra (SN)tyrosine hydroxylase (TH)voltage-gated calcium channel blocker

Substanzen

DopaminelactacystinCalcium Channel BlockersAcetylcysteineCinnarizineTyrosine 3-Monooxygenase

Autor:innen und Institutionen

  • Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.

ORCID-Profile: Elżbieta Lorenc-Koci, Tomasz Lenda, Jolanta Konieczny, Danuta Jantas, Helena Domin

Förderung

  • Statutory Fund of the Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Zitieren

APA

Lorenc-Koci, E., Lenda, T., Konieczny, J., Jantas, D., & Domin, H. (2025). Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188833

Vancouver

Lorenc-Koci E, Lenda T, Konieczny J, Jantas D, Domin H. Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188833

BibTeX
@article{LorencKoci2025,
  author = {Lorenc-Koci, Elżbieta and Lenda, Tomasz and Konieczny, Jolanta and Jantas, Danuta and Domin, Helena},
  title = {Cinnarizine, a Calcium Channel Blocker, Partially Prevents the Striatal Dopamine Decline and Loss of Nigral Dopamine Neurons in the Lactacystin-Induced Rat Model of Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26188833}
}
Kostenlos starten →